These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32917725)

  • 1. Glycerophosphodiesterase 3 (GDE3) is a lysophosphatidylinositol-specific ectophospholipase C acting as an endocannabinoid signaling switch.
    Briand-Mésange F; Pons V; Allart S; Masquelier J; Chicanne G; Beton N; Payrastre B; Muccioli GG; Ausseil J; Davignon JL; Salles JP; Chap H
    J Biol Chem; 2020 Nov; 295(46):15767-15781. PubMed ID: 32917725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Classical to Alternative Pathways of 2-Arachidonoylglycerol Synthesis: AlterAGs at the Crossroad of Endocannabinoid and Lysophospholipid Signaling.
    Briand-Mésange F; Gennero I; Salles J; Trudel S; Dahan L; Ausseil J; Payrastre B; Salles JP; Chap H
    Molecules; 2024 Aug; 29(15):. PubMed ID: 39125098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of human glycerophosphodiesterase 3 as an ecto phospholipase C that converts the G protein-coupled receptor 55 agonist lysophosphatidylinositol to bioactive monoacylglycerols in cultured mammalian cells.
    Tsutsumi T; Matsuda R; Morito K; Kawabata K; Yokota M; Nikawadori M; Inoue-Fujiwara M; Kawashima S; Hidaka M; Yamamoto T; Yamazaki N; Tanaka T; Shinohara Y; Nishi H; Tokumura A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Sep; 1865(9):158761. PubMed ID: 32629025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55.
    Yamashita A; Oka S; Tanikawa T; Hayashi Y; Nemoto-Sasaki Y; Sugiura T
    Prostaglandins Other Lipid Mediat; 2013 Dec; 107():103-16. PubMed ID: 23714700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anandamide inhibits FcεRI-dependent degranulation and cytokine synthesis in mast cells through CB
    Cruz SL; Sánchez-Miranda E; Castillo-Arellano JI; Cervantes-Villagrana RD; Ibarra-Sánchez A; González-Espinosa C
    Int Immunopharmacol; 2018 Nov; 64():298-307. PubMed ID: 30243065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain regional cannabinoid CB(1) receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice.
    Aaltonen N; Riera Ribas C; Lehtonen M; Savinainen JR; Laitinen JT
    Eur J Pharm Sci; 2014 Jan; 51():87-95. PubMed ID: 24012970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.
    Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
    Exp Gerontol; 2014 Jul; 55():134-42. PubMed ID: 24768821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.
    Ratano P; Petrella C; Forti F; Passeri PP; Morena M; Palmery M; Trezza V; Severini C; Campolongo P
    Neuropharmacology; 2018 Aug; 138():210-218. PubMed ID: 29842858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crucial Roles of the Endocannabinoid 2-Arachidonoylglycerol in the Suppression of Epileptic Seizures.
    Sugaya Y; Yamazaki M; Uchigashima M; Kobayashi K; Watanabe M; Sakimura K; Kano M
    Cell Rep; 2016 Aug; 16(5):1405-1415. PubMed ID: 27452464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of anandamide- and lysophosphatidylinositol-induced inhibition of the vasopressor responses produced by sympathetic stimulation or noradrenaline in pithed rats.
    Marichal-Cancino BA; Manrique-Maldonado G; Altamirano-Espinoza AH; Ruiz-Salinas I; González-Hernández A; Maassenvandenbrink A; Villalón CM
    Eur J Pharmacol; 2013 Dec; 721(1-3):168-77. PubMed ID: 24076186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55.
    Sharir H; Console-Bram L; Mundy C; Popoff SN; Kapur A; Abood ME
    J Neuroimmune Pharmacol; 2012 Dec; 7(4):856-65. PubMed ID: 22454039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular localization and regulation of receptors and enzymes of the endocannabinoid system in intestinal and systemic inflammation.
    Grill M; Hasenoehrl C; Kienzl M; Kargl J; Schicho R
    Histochem Cell Biol; 2019 Jan; 151(1):5-20. PubMed ID: 30196316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidylinositol Induced Morphological Changes and Stress Fiber Formation through the GPR55-RhoA-ROCK Pathway.
    Nakajima K; Oka S; Tanikawa T; Nemoto-Sasaki Y; Matsumoto N; Ishiguro H; Arata Y; Sugiura T; Yamashita A
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function.
    Kargl J; Brown AJ; Andersen L; Dorn G; Schicho R; Waldhoer M; Heinemann A
    J Pharmacol Exp Ther; 2013 Jul; 346(1):54-66. PubMed ID: 23639801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the 90-kDa heat shock protein (Hsp-90) in CB2 cannabinoid receptor-mediated cell migration: a new role of Hsp-90 in migration signaling of a G protein-coupled receptor.
    He F; Qiao ZH; Cai J; Pierce W; He DC; Song ZH
    Mol Pharmacol; 2007 Nov; 72(5):1289-300. PubMed ID: 17698952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination.
    Manterola A; Bernal-Chico A; Cipriani R; Canedo-Antelo M; Moreno-García Á; Martín-Fontecha M; Pérez-Cerdá F; Sánchez-Gómez MV; Ortega-Gutiérrez S; Brown JM; Hsu KL; Cravatt B; Matute C; Mato S
    Biochem Pharmacol; 2018 Nov; 157():189-201. PubMed ID: 30075103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction.
    Hutch CR; Hillard CJ; Jia C; Hegg CC
    Neuroscience; 2015 Aug; 300():539-53. PubMed ID: 26037800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Arachidonoylglycerol mobilizes myeloid cells and worsens heart function after acute myocardial infarction.
    Schloss MJ; Horckmans M; Guillamat-Prats R; Hering D; Lauer E; Lenglet S; Weber C; Thomas A; Steffens S
    Cardiovasc Res; 2019 Mar; 115(3):602-613. PubMed ID: 30295758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidylinositol Promotes Chemotaxis and Cytokine Synthesis in Mast Cells with Differential Participation of GPR55 and CB2 Receptors.
    Martínez-Aguilar LM; Ibarra-Sánchez A; Guerrero-Morán DJ; Macías-Silva M; Muñoz-Bello JO; Padilla A; Lizano M; González-Espinosa C
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning.
    Mosca MG; Mangini M; Cioffi S; Barba P; Mariggiò S
    Cell Commun Signal; 2021 Apr; 19(1):48. PubMed ID: 33902596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.